Fig. 2From: Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosis and type 2 diabetes mellitus: a national claims-based cohort analysisKaplan–Meier curves displaying cumulative risk of mortality (A) and hospitalizations (B) among patients with idiopathic pulmonary fibrosis with and without metformin useBack to article page